Funded Tech Companies
Hemab Therapeutics
Wondering who backed Hemab Therapeutics? Invus, Access Biotechnology and Rock Springs Capital joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Hemab Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
125 Cambridge Park Dr
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Hemab Therapeutics ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhagen, the company is led by a team of drug developers and scientists with deep expertise in haemophilia. Hemab has exclusive licences to state-of-the-art antibody technologies from both Novo Nordisk A/S and Genmab A/S.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/21/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Benny Sorensen
Chief Financial Officer
Mads Behrndt?
Chief Technical Officer
Johan Faber
Company Investors
- Invus
- Access Biotechnology
- Rock Springs Capital
- Healthcap Venture Capital
- Deep Track Capital
- Maj Invest
- Avoro Ventures
- RA Capital
- Novo Holdings
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs